Fallopian Tube Carcinoma — Trials

Fallopian Tube Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 77
Recruiting: 29
Ph III recruiting: 4
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02530606	Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer	withdrawn	N/A	0	Stanford UniversityOTHER	1	Nov 28, 2018	clinicaltrials
NCT00551265	Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy	withdrawn	N/A	0	Gynecologic Oncology GroupNETWORK	1	Jul 14, 2017	clinicaltrials